Skip to main content

Daniel N. Dang, MD

Board Certifications

Anatomic and Clinical Pathology




Gastrointestinal Pathology


  • Residency – Co-Chief Resident, University of Texas Southwestern Medical Center, Dallas, Texas
  • Medical School – University of Texas Medical Branch School of Medicine, Galveston, Texas
  • Dr. Dang received the L. Clarke Stout, Jr. Award for Excellence in Pathology, UTMB School of Medicine in 2012.
  • Joined ProPath in 2022

Peer-Reviewed Articles

  1. Dang DN, Raj G, Sarode V, Molberg KH, Vadlamudi RK, Peng Y. Significantly increased PELP1 protein expression in primary and metastatic triple-negative breast carcinoma: comparison with GATA3 expression and PELP1’s potential role in triple-negative breast carcinoma. Hum Pathol. 2015 Dec;46(12):1829-35.

  2. Dang DN, Morris HD, Feusner JH, Koduru P, Wilson K, Timmons CF, Cavalier M, Luu HS. Therapy-induced secondary acute myeloid leukemia with t(11;19)(q23;p13.1) in a pediatric patient with relapsed acute promyelocytic leukemia. J Pediatr Hematol Oncol. 2014 Nov;36(8):e546-8.

  3. Dang DN, Peng Y. Roles of p53 and p16 in triple-negative breast cancer. Breast Cancer Management. 2013;2(6):537-544.


  1. Dang DN. Ambiguous adenoma reporting leads to worse patient outcomes. USCAP Meeting, March 2017.

  2. Dang DN. Ambiguous adenoma reporting leads to worse patient outcomes [platform presentation]. Texas Society of Pathologists (Bastrop) Annual Meeting, January 2017.

  3. Dang DN. Significantly reduced E-cadherin protein expression (H-Score) in triple negative breast cancer and its correlation with Ki67. American Society for Clinical Pathology Meeting, October 2015.

  4. Dang DN. Comparison of PELP1 and GATA3 protein expression in triple-negative breast carcinoma: potential diagnostic utility in metastatic disease. USCAP Meeting, San Diego, CA, March 2014.

  5. Dang DN. Rare case of metaplastic carcinoma of the breast with exclusive sarcomatous metastasis and extensive mucinous metaplasia. CAP Meeting, Orlando, FL, October 2013.